Patents Assigned to Medivation, Inc.
  • Patent number: 7071206
    Abstract: Compounds and methods of using these compounds to treat neurodegenerative diseases, especially Alzheimer's disease, are provided. The compounds that are provided for the treatment of neurodegenerative diseases can be represented by a general formula (I): wherein R1 is Me, Et or PhCH2; R2 is H, PhCH2 or 6-Me-3-Py-(CH2)2; and R3 is H, Me or Br. The solid line accompanied by the dotted line i.e. represents a single or double bond and salts thereof with pharmacologically acceptable acids and quaternary derivatives.
    Type: Grant
    Filed: December 2, 2004
    Date of Patent: July 4, 2006
    Assignee: Medivation, Inc.
    Inventors: Nikolai S. Zefirov, Andrei Z. Afanasiev, Svetlana V. Afanasieva, Sergei O. Bachurin, Sergei E. Tkachenko, Vladmir V. Grigoriev, Marina A. Jurovskaya, Valery P. Chetverikov, Elizaveta E. Bukatina, Irina V. Grigorieva
  • Publication number: 20050096342
    Abstract: Compounds and methods of using these compounds to treat neurodegenerative diseases, especially Alzheimer's disease, are provided. The compounds that are provided for the treatment of neurodegenerative diseases can be represented by a general formula (I): wherein R1 is Me, Et or PhCH2; R2 is H, PhCH2 or 6-Me-3-Py-(CH2)2; and R3 is H, Me or Br. The solid line accompanied by the dotted line i.e. represents a single or double bond and salts thereof with pharmacologically acceptable acids and quaternary derivatives.
    Type: Application
    Filed: December 2, 2004
    Publication date: May 5, 2005
    Applicant: Medivation, Inc.
    Inventors: Nikolai Zefirov, Andrei Afanasiev, Svetlana Afanasieva, Sergei Bachurin, Sergei Tkachenko, Vladimir Grigoriev, Marina Jurovskaya, Valery Chetverikov, Elizaveta Bukatina, Irina Grigorieva